Home > Specialties > Stents, Vascular, Coronary, Balloon-Expandable, Drug-Eluting

Stents, Vascular, Coronary, Balloon-Expandable, Drug-Eluting

Definition : Balloon-expandable coronary stents that include a drug on their surface (e.g., immunosuppressors such as sirolimus and tacrolimus, cytostatics such as taxol and its derivative, paclitaxel) that is released into the surrounding tissue over time (typically several weeks). The drug is usually placed on the stent surface using a polymeric coating or a special drug-eluting sleeve. Drug-eluting coronary stents are intended to slow down the growth of unwanted cells (restenosis) without inhibiting the endothelialization of the inner layer (i.e., intima) of the artery.

Entry Terms : "Drug-Eluting Stents (DES), Coronary Artery" , "Drug-Eluting Coronary Stents"

UMDC code : 20383

U.S.companies only
Suppress Subsidiary Companies

1-3 of 3 Match(es).

Implant Sciences Corp

Company Type: Parent

Implant Sciences Corporation (IMSC:OTCPK) develops and commercializes explosives trace detection (ETD) solutions for transportation and aviation security, force protection and law enforcement, critical infrastructure protection, and public safety markets.

InSitu Technologies Inc

Company Type: Parent

InSitu Technologies Inc. is a privately held medical device company specializing in intra-vascular stents and cardiovascular products. InSitu Technologies is dedicated to providing the world with a full portfolio of state-of-the-art minimally invasive products with a strong focus on the well being of our patients.

Medtronic Inc

Company Type: Parent

At Medtronic, we're changing the face of chronic disease. By working closely with physicians around the world, we create therapies to help patients do things they never thought possible.

1-3 of 3 Match(es).